Literature DB >> 15537917

Oligospermia in a patient receiving imatinib therapy for the hypereosinophilic syndrome.

Tara Seshadri, John F Seymour, Grant A McArthur.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537917     DOI: 10.1056/NEJM200411113512024

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  Effects of chemotherapy and radiotherapy on spermatogenesis in humans.

Authors:  Marvin L Meistrich
Journal:  Fertil Steril       Date:  2013-09-04       Impact factor: 7.329

2.  Will imatinib compromise reproductive capacity?

Authors:  Alberuni M Zamah; Michael J Mauro; Brian J Druker; Kutluk Oktay; Merrill J Egorin; Marcelle I Cedars; Mitchell P Rosen
Journal:  Oncologist       Date:  2011-09-23

3.  Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.

Authors:  Nobuko Hijiya; Kirk R Schultz; Markus Metzler; Frederic Millot; Meinolf Suttorp
Journal:  Blood       Date:  2015-10-28       Impact factor: 22.113

Review 4.  Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia.

Authors:  Kathryn E Flynn; Ehab Atallah
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

5.  Imatinib has deleterious effects on differentiating spermatogonia while sparing spermatogonial stem cell self renewal.

Authors:  Crystal Heim; Kayla Minniear; Christina Tenenhaus Dann
Journal:  Reprod Toxicol       Date:  2011-02-01       Impact factor: 3.143

6.  Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase.

Authors:  Xiaohui Chang; Lin Zhou; Xiaoxia Chen; Baoli Xu; Yubin Cheng; Shujun Sun; Meiyun Fang; Yang Xiang
Journal:  Target Oncol       Date:  2017-12       Impact factor: 4.493

Review 7.  Oncofertility: Meeting the Fertility Goals of Adolescents and Young Adults With Cancer.

Authors:  H Irene Su; Yuton Tony Lee; Ronald Barr
Journal:  Cancer J       Date:  2018 Nov/Dec       Impact factor: 3.360

Review 8.  Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Authors:  Ayalew Tefferi; Jason Gotlib; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2010-01-06       Impact factor: 7.616

9.  Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.

Authors:  A Mukhopadhyay; S Dasgupta; U Kanti Ray; F Gharami; C K Bose; S Mukhopadhyay
Journal:  Ir J Med Sci       Date:  2014-03-04       Impact factor: 1.568

Review 10.  Targeting developmental pathways in children with cancer: what price success?

Authors:  Lia Gore; James DeGregori; Christopher C Porter
Journal:  Lancet Oncol       Date:  2013-02       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.